Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) — The “Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User (Hospital) – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
The global patient registry software market is projected to reach USD 2,410.2 million by 2025 from USD 1,229.2 million in 2020, at a CAGR of 14.4% from 2020 to 2025.
The shift toward computerized registries from paper-based registries, due to their advantages, is a key driver of market growth. The emergence of the COVID-19 pandemic and the increase in the number of COVID-19 patients globally is also expected to support the demand for patient registry software. Other considerations include the rising number of accountable care organizations, high adoption of the subscription model, and the emergence of cloud-based patient registry solutions.
In this report, the patient registry software market has been segmented based on the type of registry, software, pricing model, deployment model, type of database, functionality, end-user, and region.
Prominent players in the patient registry software market include Phytel, IQVIA Holdings, OpenText Corporation, Dacima Software, Global Vision Technologies, IFA systems, Syneos Health, and HealthDiary.